Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Heidi Chen

Showing results (181-190 of 207) with videos related to

Pageof 21
Sort By:
Medrxiv : the Preprint Server for Health Sciences|February 6, 2026
Longitudinal Analysis of CYFRA 21-1 Levels in Patients with Pulmonary Nodules: Differential Trajectories Between Benign and Malignant Cases and Impact of Tumor ResectionYency J Forero, Michael N Kammer, Kevin C McGann, et al.
Trials|May 13, 2026
Assessing a biomarker platform for stratifying indeterminate pulmonary nodules, protocol for the SPOT IT randomized trialRafael Paez, Timothy A Khalil, Yency Forero, et al.
JTO Clinical and Research Reports|September 7, 2023
Tumoral Densities of T-Cells and Mast Cells Are Associated With Recurrence in Early-Stage Lung AdenocarcinomaMichael N Kammer, Hidetoshi Mori, Dianna J Rowe, et al.
Scientific Reports|April 15, 2023
Longitudinal lung cancer prediction convolutional neural network model improves the classification of indeterminate pulmonary nodulesRafael Paez, Michael N Kammer, Aneri Balar, et al.
JTO Clinical and Research Reports|September 30, 2021
Blood-Based Surveillance Monitoring of Circulating Tumor DNA From Patients With SCLC Detects Disease Relapse and Predicts Death in Patients With Limited-Stage DiseaseWade T Iams, Prasad R Kopparapu, Yingjun Yan, et al.
Plos One|June 23, 2026
Longitudinal analysis of CYFRA 21-1 levels in patients with pulmonary nodules: Differential trajectories between benign and malignant casesYency J Forero, Michael N Kammer, Kevin C McGann, et al.
American Journal of Respiratory and Critical Care Medicine|April 25, 2020
Assessing the Accuracy of a Deep Learning Method to Risk Stratify Indeterminate Pulmonary NodulesPierre P Massion, Sanja Antic, Sarim Ather, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|March 5, 2015
Multi-institutional Oncogenic Driver Mutation Analysis in Lung Adenocarcinoma: The Lung Cancer Mutation Consortium ExperienceLynette M Sholl, Dara L Aisner, Marileila Varella-Garcia, et al.
Elife|October 4, 2018
Bid maintains mitochondrial cristae structure and function and protects against cardiac disease in an integrative genomics studyChristi T Salisbury-Ruf, Clinton C Bertram, Aurelia Vergeade, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 2007
Predictive and pharmacodynamic biomarker studies in tumor and skin tissue samples of patients with recurrent or metastatic squamous cell carcinoma of the head and neck treated with erlotinibMark Agulnik, Gilda da Cunha Santos, David Hedley, et al.
Pageof 21

Showing results (181-190 of 207) with videos related to

Sort By:
Pageof 21
Medrxiv : the Preprint Server for Health Sciences|February 6, 2026
Longitudinal Analysis of CYFRA 21-1 Levels in Patients with Pulmonary Nodules: Differential Trajectories Between Benign and Malignant Cases and Impact of Tumor ResectionYency J Forero, Michael N Kammer, Kevin C McGann, et al.
Trials|May 13, 2026
Assessing a biomarker platform for stratifying indeterminate pulmonary nodules, protocol for the SPOT IT randomized trialRafael Paez, Timothy A Khalil, Yency Forero, et al.
JTO Clinical and Research Reports|September 7, 2023
Tumoral Densities of T-Cells and Mast Cells Are Associated With Recurrence in Early-Stage Lung AdenocarcinomaMichael N Kammer, Hidetoshi Mori, Dianna J Rowe, et al.
Scientific Reports|April 15, 2023
Longitudinal lung cancer prediction convolutional neural network model improves the classification of indeterminate pulmonary nodulesRafael Paez, Michael N Kammer, Aneri Balar, et al.
JTO Clinical and Research Reports|September 30, 2021
Blood-Based Surveillance Monitoring of Circulating Tumor DNA From Patients With SCLC Detects Disease Relapse and Predicts Death in Patients With Limited-Stage DiseaseWade T Iams, Prasad R Kopparapu, Yingjun Yan, et al.
Plos One|June 23, 2026
Longitudinal analysis of CYFRA 21-1 levels in patients with pulmonary nodules: Differential trajectories between benign and malignant casesYency J Forero, Michael N Kammer, Kevin C McGann, et al.
American Journal of Respiratory and Critical Care Medicine|April 25, 2020
Assessing the Accuracy of a Deep Learning Method to Risk Stratify Indeterminate Pulmonary NodulesPierre P Massion, Sanja Antic, Sarim Ather, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|March 5, 2015
Multi-institutional Oncogenic Driver Mutation Analysis in Lung Adenocarcinoma: The Lung Cancer Mutation Consortium ExperienceLynette M Sholl, Dara L Aisner, Marileila Varella-Garcia, et al.
Elife|October 4, 2018
Bid maintains mitochondrial cristae structure and function and protects against cardiac disease in an integrative genomics studyChristi T Salisbury-Ruf, Clinton C Bertram, Aurelia Vergeade, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 2007
Predictive and pharmacodynamic biomarker studies in tumor and skin tissue samples of patients with recurrent or metastatic squamous cell carcinoma of the head and neck treated with erlotinibMark Agulnik, Gilda da Cunha Santos, David Hedley, et al.
Pageof 21